Therapy outcome related to adalimumab trough levels in pediatric patients with inflammatory bowel disease. Lehtomaki J, Nikkonen A, Merras-Salmio L, Hiltunen P, et al. Scand J Gastroenterol 2021 Sep 21:1-6. doi: 10.1080/00365521.2021.1977843.

Read + Share

Amedeo Smart

Independent Medical Education

Lehtomaki J, Nikkonen A, Merras-Salmio L, Hiltunen P, et al. Therapy outcome related to adalimumab trough levels in pediatric patients with inflammatory bowel disease. Scand J Gastroenterol 2021 Sep 21:1-6. doi: 10.1080/00365521.2021.1977843.
PMID: 34546843